Dr. Katie O’Brien discusses psychedelics, mental health, consciousness, and life transitions during perimenopause and menopause.

Psychedelics, Mental Health & Consciousness in Midlife

September 05, 20266 min read

Psychedelics, Mental Health & Consciousness

Exploring Neuroplasticity, Emotional Health, and Life Transitions During Perimenopause and Menopause

A Word of Caution Before We Begin

“Psychedelics are not magic, and they are not new.”

There is an extraordinary amount of interest right now in psychedelics and their potential role in mental health.

But this conversation requires context.

Many psychedelic substances remain highly regulated, and several therapies currently being studied are still investigational. This article is not a recommendation for recreational or unsupervised psychedelic use.

Instead, Dr. Katie O’Brien shares the emerging science, history, and broader conversation taking place in medicine so women can stay informed, grounded, and curious as this field evolves.

The FDA continues to support research into psychedelic drugs for serious mental health conditions and finalized guidance for clinical investigations in July 2026, reflecting how rapidly this area of medicine is developing.


Why This Conversation Matters During Midlife

Perimenopause and menopause are hormonal transitions—but they can also be deeply emotional and psychological ones.

Women may experience changes in:

  • Identity

  • Family roles

  • Relationships

  • Community

  • Priorities

  • Emotional well-being

  • Life direction

For many women, this season brings bigger questions:

Who am I now?
What matters to me now?
What am I moving toward?
Why am I here?

Dr. Katie believes these questions matter.

In many traditional cultures, major transitions were marked by reflection, ritual, community, and meaning-making rather than something to simply rush through.

That is part of what makes the modern conversation around psychedelics, consciousness, and psychological flexibility particularly interesting during midlife.


Psychedelics Are Not New

Psychedelics may feel like a modern wellness trend, but humans have interacted with psychoactive plants and compounds for thousands of years.

Traditional practices involving substances such as psilocybin-containing mushrooms, ayahuasca, peyote, and iboga developed within specific cultural and spiritual frameworks.

The important point isn't simply the substance.

It's the context.

Historically, these experiences were often:

  • Intentional

  • Structured

  • Guided

  • Community-based

  • Connected with healing or spiritual practice

  • Followed by reflection and meaning-making

Modern medicine is now studying some of the same compounds through a very different scientific and clinical lens.


What Do We Mean by “Psychedelics”?

Dr. Katie discusses several compounds currently receiving attention in medicine and mental health research, including:

  • Psilocybin

  • MDMA

  • Ketamine

  • Ibogaine

  • DMT

  • 5-MeO-DMT

These compounds are different from one another and should not be grouped together as though they have identical effects, risks, or evidence.

Some remain investigational, while others, such as ketamine, already have established medical uses outside psychedelic-assisted therapy.

The larger question researchers are asking is whether certain compounds could temporarily create conditions in which the brain becomes more receptive to psychological and behavioral change.


Neuroplasticity: Creating an Opportunity for Change

One of the most fascinating areas of psychedelic research involves neuroplasticity.

Neuroplasticity describes the brain's ability to adapt, reorganize, and create new connections.

As Dr. Katie explains in the podcast, some psychedelic compounds are being studied for their potential to temporarily increase the brain's capacity for change.

That doesn't mean the substance itself automatically creates transformation.

Instead, it may create an opening.

An opportunity to examine old patterns differently.

An opportunity to become more psychologically flexible.

And perhaps an opportunity to respond to familiar thoughts, behaviors, or emotional experiences in a new way.


What Is Psychological Flexibility?

Dr. Katie uses a term she particularly likes:

Psychological flexibility.

We all develop patterns.

Certain stories about ourselves become familiar. Thoughts repeat. Emotional responses become automatic.

Sometimes those patterns can feel like deep ruts.

Researchers are exploring whether psychedelic experiences may temporarily soften some of these entrenched patterns, potentially allowing individuals to approach their thoughts and experiences differently.

The goal isn't simply to have an unusual experience.

The goal is what may become possible afterward.


Set, Setting & Integration Matter

This is one of Dr. Katie's biggest takeaways from the conversation.

Set

  • Your mindset, emotional preparedness, intentions, and openness going into an experience.

Setting

  • The physical environment, safety, professional guidance, and support surrounding the experience.

Integration

  • What happens afterward.

Integration is the process of reflecting on an experience and translating insights into meaningful changes in everyday life.

As Dr. Katie explains, an insight alone does not necessarily create transformation.

Insight → Meaning → Behavioral Change → Lasting Transformation

This is one of the reasons professionally supported psychedelic research is very different from recreational psychedelic use.


What Is the Research Exploring?

Researchers are currently investigating psychedelic and related therapies across several areas of mental health, including:

  • Treatment-resistant depression

  • PTSD

  • Substance use disorders

  • Existential distress

  • Anxiety and emotional processing

  • Psychological flexibility

The research is still evolving, and different compounds have very different levels of evidence.

FDA guidance emphasizes that psychedelic drug programs must meet the same evidentiary standards for safety and effectiveness as other medications, while recognizing that studying these compounds presents unique challenges.

This is a developing field—not a settled one.


Menopause Is More Than a Hormonal Transition

The connection Dr. Katie makes between psychedelics and menopause isn't simply about treating symptoms.

It's about transition.

Perimenopause and menopause can become a period of reevaluating:

  • Who we are

  • What we value

  • Where we spend our energy

  • Which relationships matter

  • What we want the next chapter of our lives to look like

This can be uncomfortable.

But it can also be meaningful.

Dr. Katie doesn't present psychedelics as the answer to this transition.

Instead, she sees the broader conversation as an opportunity to think differently about mental health, consciousness, emotional processing, and our ability to change throughout life.


Psychedelics Are Tools, Not Quick Fixes

This may be the most important takeaway from the entire conversation.

Psychedelics are not magic.

And taking a substance cannot replace the deeper work of understanding yourself, changing behaviors, developing healthy relationships, or addressing the foundations of your mental and physical health.

When these compounds are being studied therapeutically, preparation and professional support matter.

The experience itself may only be one component.

The work that comes afterward can be just as important.


What Does the Future Hold?

The landscape is changing quickly.

Researchers, regulators, physicians, and mental health professionals are continuing to explore whether psychedelic-assisted therapies could eventually become part of more structured treatment models for certain conditions.

The FDA's current guidance specifically addresses clinical development of psychedelic drugs for conditions such as psychiatric and substance use disorders, showing that this area has moved into a serious regulatory and scientific conversation.

There is still much we don't know.

Long-term safety, appropriate patient selection, dosing, professional support, and integration all require continued study.

But Dr. Katie remains hopeful about what this research could eventually mean for mental health care.


Final Thoughts

Psychedelics have existed for thousands of years.

What's changing is the way modern medicine is beginning to study them.

For women navigating perimenopause and menopause, this conversation also opens the door to something larger:

How do we approach transition?

How capable is the brain of changing?

How do we create meaning from difficult or transformative periods of our lives?

And how might mental health care evolve from simply managing symptoms toward helping people create meaningful change?

Dr. Katie's message is simple:

Stay curious.

Stay grounded.

And remember that your health, your brain, and your journey are deeply individual.


Watch The Full Podcast

Custom HTML/CSS/JavaScript

Want to hear the full conversation from Dr. Katie O’Brien?

Watch the complete podcast episode here: The Psychedelics Conversation Women Need to Hear | Dr. Katie O’Brien

If this conversation resonated with you, be sure to explore more education and resources from Tahoe Hormone Therapy focused on hormone health, metabolism, strength, longevity, and thriving through perimenopause and menopause.

Want More Support?

At Tahoe Hormone Therapy, we help women navigate perimenopause, menopause, metabolic health, hormone balance, and longevity through a personalized, root-cause approach.

If you're ready to feel healthier, stronger, and more supported in your next chapter, we'd love to help.

Learn More about Tahoe Hormone Therapy

Dr. Katie O’Brien, MD, MPH, IFMCP

Dr. Katie O’Brien, MD, MPH, IFMCP

Dr. Katie O’Brien is a functional medicine physician specializing in hormone health, metabolism, longevity, and women’s wellness during perimenopause and menopause. Through Tahoe Hormone Therapy, she helps women build strength, restore energy, and optimize long-term health through a science-backed, compassionate approach.

Youtube logo icon
Back to Blog